118 related articles for article (PubMed ID: 1423963)
41. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
Lin JS; Lui SM; Chen CM; Chang WC
J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
[TBL] [Abstract][Full Text] [Related]
42. Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans.
Wennmalm A; Fitzgerald GA
Am J Physiol; 1988 Jul; 255(1 Pt 2):H15-8. PubMed ID: 3293469
[TBL] [Abstract][Full Text] [Related]
43. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
Reilly IA; Roy L; Fitzgerald GA
Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1037-9. PubMed ID: 3083991
[TBL] [Abstract][Full Text] [Related]
44. Eicosenoid biosynthesis and platelet function with advancing age.
Reilly IA; FitzGerald GA
Thromb Res; 1986 Feb; 41(4):545-54. PubMed ID: 3754355
[TBL] [Abstract][Full Text] [Related]
45. Effect of oral contraceptives containing 20 and 35 µg ethinyl estradiol on urinary prostacyclin and thromboxane levels in smokers and non-smokers.
Ploszaj S; Thornton MH; Stanczyk FZ; Mishell DR
Prim Care Update Ob Gyns; 1998 Jul; 5(4):156. PubMed ID: 10838290
[TBL] [Abstract][Full Text] [Related]
46. Percutaneous transluminal angioplasty increases thromboxane A2 production in claudicants.
Rossi P; Kuukasjärvi P; Salenius JP; Tarkka M; Kerttula T; Alanko J; Mucha I; Riutta A
Prostaglandins Leukot Essent Fatty Acids; 1997 May; 56(5):369-72. PubMed ID: 9175173
[TBL] [Abstract][Full Text] [Related]
47. Significance of urinary 11-dehydro-thromboxane B
Simeone P; Boccatonda A; Liani R; Santilli F
Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
[TBL] [Abstract][Full Text] [Related]
48. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Reilly IA; Doran JB; Smith B; FitzGerald GA
Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
[TBL] [Abstract][Full Text] [Related]
49. Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects.
Ylikorkala O; Halmesmäki E; Viinikka L
Obstet Gynecol; 1988 Jan; 71(1):61-6. PubMed ID: 3275910
[TBL] [Abstract][Full Text] [Related]
50. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
51. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
Adatia I; Barrow SE; Stratton PD; Miall-Allen VM; Ritter JM; Haworth SG
Circulation; 1993 Nov; 88(5 Pt 1):2117-22. PubMed ID: 8222105
[TBL] [Abstract][Full Text] [Related]
52. Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease.
Stichtenoth DO; Kreutzer FJ; Gutzki FM; Tsikas D; Nowak V; Frölich JC
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):211-4. PubMed ID: 11728174
[TBL] [Abstract][Full Text] [Related]
53. Platelet activation in unstable coronary disease.
Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
[TBL] [Abstract][Full Text] [Related]
54. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
55. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
Adatia I; Barrow SE; Stratton P; Ritter JM; Haworth SG
Br Heart J; 1993 Feb; 69(2):179-82. PubMed ID: 8435245
[TBL] [Abstract][Full Text] [Related]
56. Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus.
Inui Y; Suehiro T; Kumon Y; Hashimoto K
J Atheroscler Thromb; 1994; 1(2):108-12. PubMed ID: 9222878
[TBL] [Abstract][Full Text] [Related]
57. Thromboxane biosynthesis and platelet function in type I diabetes mellitus.
Alessandrini P; McRae J; Feman S; FitzGerald GA
N Engl J Med; 1988 Jul; 319(4):208-12. PubMed ID: 3292913
[TBL] [Abstract][Full Text] [Related]
58. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
[TBL] [Abstract][Full Text] [Related]
59. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
[TBL] [Abstract][Full Text] [Related]
60. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]